Dynavax Technologies said on Thursday its experimental shingles vaccine generated a similar immune response as GSK's ...

A study published this week in the peer-reviewed journal Scientific Reports examined the long-term impacts of having shingles ...

Shingles is a viral infection that causes pain and discomfort. Unfortunately, one sign you have it is easy to miss, as it ...

Results from the first part of a Phase I/II trial (NCT06569823) showed that Z-1018 generated immune responses comparable to ...

The Emeryville, California-based biotech has just released topline results from a phase 1/2 head-to-head study comparing its ...

Shares of Dynavax rose after the company released positive results from a trial of its shingles vaccine tested against current Shingles vaccine Shingrix. The stock was up 6.7% to $11.12 but is still ...

In the US, the CDC recommends shingles vaccination for all adults aged 50 and older. However, uptake has been low, partly due to limited awareness, cost concerns, and missed opportunities during ...

Shingles will strike 1 in 3 Americans during their lifetimes — most between ages 60 and 70. Folks in their 60s get shingles at roughly twice the rate as folks in their 50s, reports the CDC.

Despite how common shingles is, there's a lot of misinformation out there—which we're happy to clear up. Here are six myths and the facts you need to protect yourself.

FOX 32's Elizabeth Matthews shares her painful and vision-threatening battle with shingles on her face and eye to raise awareness that the illness can strike younger, healthy adults.

One of the goals of the Insurance Institute for Business and Home Safety is to make homes and commercial buildings stronger.